第 1 到 8 筆結果,共 8 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile | KAI-WEN HUANG ; Reebye V.; Czysz K.; Ciriello S.; Dorman S.; Reccia I.; HONG-SHIEE LAI ; Peng L.; Kostomitsopoulos N.; Nicholls J.; Habib R.S.; Tomalia D.A.; S?trom P.; Wilkes E.; Cutillas P.; Rossi J.J.; Habib N.A. | Molecular Therapy - Nucleic Acids | 38 | 34 | |
2 | 2019 | Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice | Zhou J.; Li H.; Xia X.; Herrera A.; Pollock N.; Reebye V.; Sodergren M.H.; Dorman S.; Littman B.H.; Doogan D.; KAI-WEN HUANG ; Habib R.; Blakey D.; Habib N.A.; Rossi J.J. | Molecular Therapy | 11 | 11 | |
3 | 2019 | Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC | Yoon S.; KAI-WEN HUANG ; Andrikakou P.; Vasconcelos D.; Swiderski P.; Reebye V.; Sodergren M.; Habib N.; Rossi J.J. | Molecular Therapy - Nucleic Acids | 21 | 16 | |
4 | 2018 | Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer | Reebye V.; KAI-WEN HUANG ; Lin V.; Jarvis S.; Cutilas P.; Dorman S.; Ciriello S.; Andrikakou P.; Voutila J.; Saetrom P.; Mintz P.J.; Reccia I.; Rossi J.J.; Huber H.; Habib R.; Kostomitsopoulos N.; Blakey D.C.; Habib N.A. | Oncogene | 63 | 54 | |
5 | 2017 | Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth | Yoon S.; KAI-WEN HUANG ; Reebye V.; Spalding D.; Przytycka T.M.; Wang Y.; Swiderski P.; Li L.; Armstrong B.; Reccia I.; Zacharoulis D.; Dimas K.; Kusano T.; Shively J.; Habib N.; Rossi J.J. | Molecular Therapy - Nucleic Acids | 64 | 58 | |
6 | 2016 | Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth in Vivo | Yoon S.; KAI-WEN HUANG ; Reebye V.; Mintz P.; YU-WEN TIEN ; HONG-SHIEE LAI ; S?trom P.; Reccia I.; Swiderski P.; Armstrong B.; Jozwiak A.; Spalding D.; Jiao L.; Habib N.; Rossi J.J. | Molecular Therapy | 52 | 50 | |
7 | 2014 | Exploiting human CD34+ stem cell-conditioned medium for tissue repair | Mintz P.J.; KAI-WEN HUANG ; Reebye V.; Nteliopoulos G.; HONG-SHIEE LAI ; S?trom P.; Kasahara N.; Jensen S.; Pai M.; Gordon M.Y.A.; Marley S.B.; Behan R.; Spalding D.R.; Haoudi A.; Emara M.M.; Nicholls J.; Rossi J.J.; Habib N.A. | Molecular Therapy | 8 | 8 | |
8 | 2014 | Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo | Reebye V.; S?trom P.; Mintz P.J.; KAI-WEN HUANG ; Swiderski P.; Peng L.; Liu C.; Liu X.; Lindk?r-Jensen S.; Zacharoulis D.; Kostomitsopoulos N.; Kasahara N.; Nicholls J.P.; Jiao L.R.; Pai M.; Spalding D.R.; Mizandari M.; Chikovani T.; Emara M.M.; Haoudi A.; Tomalia D.A.; Rossi J.J.; Habib N.A. | Hepatology | 94 | 91 |